An approvable letter is sent by the FDA when a drugmaker's New Drug Application is not sufficient for approval, but has the potential to be approved at a later date. The letter spells out what problems the FDA had with the marketing application. Often times further meetings with the FDA are required to determine what needs to be done to get the drug approved.
Recent Mentions on Fool.com
- 3 Speculative Growth Stocks That Might Be Worth the Risk
- Dealing With Debt Collectors the Right Way
- Is Northrop Grumman's Latest Share Buyback Program a Good Deal for Shareholders?
- Why Biotech Stocks Fell Sharply Today
- Want Lower Drug Prices? Here's How the FDA Can Help
- 8 Ways to Increase Your Credit Score to Get the Lowest Mortgage Rates